NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ABT

Abbott Laboratories

Jun 30 • 04:00PM ET

136.01

Dollar change +1.63
Percentage change 1.21	%

Healthcare • Medical Devices • USA • NYSE

Peers: JNJ MDT DHR BAX SYK ISRG TDOC BDX RMD ZBH

| Held by: VTI VOO SPY IVV VTV XLV VIG VYM IHI VHT

Scroll to Statements

Index	S&P 500	P/E	17.64	EPS (ttm)	7.71	Insider Own	0.67%	Shs Outstand	1.74B	Perf Week	2.06%
Market Cap	236.64B	Forward P/E	23.91	EPS next Y	5.69	Insider Trans	-4.89%	Shs Float	1.73B	Perf Month	2.38%
Enterprise Value	243.29B	PEG	1.70	EPS next Q	1.25	Inst Own	79.81%	Short Float	1.20%	Perf Quarter	3.97%
Income	13.43B	P/S	5.59	EPS this Y	10.49%	Inst Trans	2.14%	Short Ratio	3.05	Perf Half Y	18.52%
Sales	42.34B	P/B	4.85	EPS next Y	10.25%	ROA	17.45%	Short Interest	20.80M	Perf YTD	20.25%
Book/sh	28.05	P/C	34.58	EPS next 5Y	10.36%	ROE	30.66%	52W High	141.23 -3.70%	Perf Year	29.68%
Cash/sh	3.93	P/FCF	35.55	EPS past 3/5Y	24.73% 29.98%	ROIC	21.82%	52W Low	99.71 36.41%	Perf 3Y	28.06%
Dividend Est.	2.40 (1.76%)	EV/EBITDA	23.50	Sales past 3/5Y	-0.88% 5.63%	Gross Margin	51.42%	Volatility	2.70% 1.84%	Perf 5Y	48.97%
Dividend TTM	2.28 (1.68%)	EV/Sales	5.75	EPS Y/Y TTM	139.98%	Oper. Margin	16.96%	ATR (14)	2.59	Perf 10Y	171.86%
Dividend Ex-Date	Jul 15, 2025	Quick Ratio	1.27	Sales Y/Y TTM	5.00%	Profit Margin	31.72%	RSI (14)	55.89	Recom	1.90
Dividend Gr. 3/5Y	7.17% 11.16%	Current Ratio	1.78	EPS Q/Q	6.70%	SMA20	1.23%	Beta	0.73	Target Price	143.09
Payout	29.33%	Debt/Eq	0.27	Sales Q/Q	3.95%	SMA50	2.34%	Rel Volume	0.83	Prev Close	134.38
Employees	114000	LT Debt/Eq	0.26	Earnings	Jul 17 BMO	SMA200	9.61%	Avg Volume	6.83M	Price	136.01
IPO	Mar 01, 1937	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.66% -0.46%	Trades		Volume	5,681,505	Change	1.21%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-25	Initiated	Leerink Partners	Market Perform	$143
Oct-08-24	Initiated	Oppenheimer	Outperform	$130
Sep-19-24	Initiated	Piper Sandler	Overweight	$131
Jul-30-24	Downgrade	Edward Jones	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$121
Jul-21-23	Upgrade	Wolfe Research	Underperform → Peer Perform
May-30-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$112
Apr-20-23	Reiterated	Wolfe Research	Underperform	$107 → $103
Apr-20-23	Reiterated	UBS	Buy	$117 → $130
Apr-20-23	Reiterated	Raymond James	Outperform	$116 → $123
Apr-20-23	Reiterated	JP Morgan	Overweight	$118 → $122
Apr-20-23	Reiterated	Bernstein	Outperform	$132 → $133
Apr-20-23	Reiterated	Barclays	Overweight	$125 → $127
Mar-29-23	Initiated	UBS	Buy	$117
Oct-26-22	Initiated	Mizuho	Neutral	$105
Oct-18-22	Initiated	Barclays	Overweight	$118
Oct-12-22	Initiated	Jefferies	Hold	$110
Jul-06-22	Initiated	Wolfe Research	Underperform	$95
Mar-02-22	Resumed	BofA Securities	Buy	$140
Jan-27-22	Reiterated	UBS	Buy	$138 → $142

Show Previous Ratings

Jun-30-25 06:46AM	New CGM pump expands market reach and clinical utility (Medical Device Network)
06:22AM	What to Expect From Abbott Laboratories' Q2 2025 Earnings Report (Barchart)
Jun-28-25 05:49AM	Got $500? 2 Healthcare Stocks to Buy and Hold Forever (Motley Fool)
01:27AM	Abbott Laboratories (ABT) Surged Ahead of the Market in 2025 with Steady Earnings Momentum (Insider Monkey)
Jun-26-25 06:00PM	Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
01:26PM	Loading…
01:26PM	Governor announces first Texas Energy Fund loan for 122 MW natural gas facility (Reuters)
11:40AM	NVST vs. ABT: Which Stock Is the Better Value Option? (Zacks)
09:00AM	Abbott Hosts Conference Call for Second-Quarter Earnings (PR Newswire)
08:45AM	Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever (Motley Fool)
Jun-25-25 03:08PM	Oppenheimer Sees Strong Upside for Abbott (ABT) with Volt System and Diabetes Innovation (Insider Monkey)
01:12PM	John Paul Mitchell Systems joins companies moving headquarters to Texas from California (Austin American-Statesman)
12:15PM	Diabetes stocks rally after RFK comments on HHS campaign (TipRanks)
11:07AM	Tandems Elizabeth Gasser on patch pump plans, Abbott partnership (MedTech Dive)
Jun-24-25 07:00PM	Analyst Report: Abbott Laboratories (Morningstar Research)
09:33AM	Should You Continue to Retain Abbott Stock in Your Portfolio Now? (Zacks)
09:00AM	Loading…
09:00AM	3 Dirt-Cheap Dividend Aristocrats About to Explode Higher (Barchart)
06:56AM	ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors (MedTech Dive)
Jun-23-25 11:20AM	BBNX Stock May Gain From Abbott Deal to Advance iLet Integration (Zacks)
07:14AM	Tandems t:slim X2 pump now works with Abbotts FreeStyle CGM sensor (Medical Device Network)
05:37AM	The Zacks Analyst Blog Highlights Meta, Palantir, Abbott Laboratories, SandRidge and CompX (Zacks)
Jun-20-25 07:30PM	New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier (PR Newswire)
04:20PM	Top Research Reports for Meta Platforms, Palantir & Abbott (Zacks)
09:25AM	DXCM's Access Gains and Operational Strength Offset Margin Pressures (Zacks)
08:30AM	Tandem Diabetes Care Announces t:slim X2 Insulin Pump Compatibility with Abbotts FreeStyle Libre® 3 Plus Sensor in the United States (Business Wire)
07:06AM	5 things to watch at the ADAs Scientific Sessions (MedTech Dive)
Jun-19-25 09:00AM	Is Trending Stock Abbott Laboratories (ABT) a Buy Now? (Zacks)
08:18AM	ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise? (Zacks)
07:00AM	Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbotts Future Dual Glucose-Ketone Sensor (GlobeNewswire)
Jun-18-25 09:12AM	BSX's Neuromodulation Arm Sees Growth: Q1 Highlights (Zacks)
08:40AM	Aurora Cannabis Inc. (ACB) Misses Q4 Earnings Estimates (Zacks)
07:34AM	Loading…
07:34AM	Esker Expands European Field Presence with New Office in Ghent, Belgium (GlobeNewswire)
06:20AM	Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? (Zacks)
03:13AM	Leerink Partners Begins Coverage on ABT (Insider Monkey)
Jun-17-25 03:22PM	3 Dividend Growth Stocks To Buy and Hold Forever (Barchart)
08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
06:20AM	Should You Invest in the iShares U.S. Medical Devices ETF (IHI)? (Zacks)
02:23AM	Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management (Insider Monkey)
12:01AM	Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jun-16-25 05:50PM	Abbott (ABT) Stock Dips While Market Gains: Key Facts (Zacks)
09:54AM	Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings (Investing.com)
08:00AM	Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions (PR Newswire)
Jun-15-25 05:23AM	Jim Cramer Calls Abbott "Really Excellent" (Insider Monkey)
Jun-13-25 11:34AM	Abbott Declares 406th Consecutive Quarterly Dividend (PR Newswire)
Jun-12-25 02:12PM	Abbott Laboratories Stock Sees RS Rating Rise To 82 (Investor's Business Daily)
Jun-11-25 05:00AM	5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off (Motley Fool)
Jun-10-25 11:40AM	NVST vs. ABT: Which Stock Should Value Investors Buy Now? (Zacks)
08:53AM	Cardiovascular Tailwind Boosts BSX: Here's How to Play the Stock (Zacks)
Jun-06-25 04:08PM	Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? (MarketWatch)
12:13PM	Omada Health goes public at $23 per share, marking second major digital health IPO in 2025 (Yahoo Finance)
12:13PM	Omada Health goes public at $23 per share, marking second digital health IPO in 2025 (Yahoo Finance)
Jun-05-25 09:30AM	Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
Jun-04-25 05:50PM	Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
09:04AM	Emerging Markets Power Boston Scientific: Will the Growth Trend Continue? (Zacks)
09:00AM	Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jun-03-25 10:30AM	Media Groups Probed by FTC Over Coordinating Boycott Claims (Bloomberg)
May-30-25 10:09AM	Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds (Zacks)
May-29-25 05:50PM	Abbott (ABT) Rises Higher Than Market: Key Facts (Zacks)
May-28-25 10:17AM	How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott (Investor's Business Daily)
10:14AM	How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals (Investor's Business Daily)
09:22AM	Abbott Stock Gains Following FDA Approval of the Tendyne System (Zacks)
05:51AM	The Zacks Analyst Blog Highlights Coca-Cola, Abbott Laboratories and AT&T (Zacks)
May-27-25 08:58PM	Abbott Gains FDA Approval for Tendyne, Strengthening Its Minimally Invasive Heart Portfolio (Insider Monkey)
04:21PM	Top Stock Reports for Coca-Cola, Abbott & AT&T (Zacks)
09:00AM	Abbott Receives FDA Approval for Tendyne, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery (PR Newswire)
May-24-25 10:00PM	If You Invested $10K In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
May-23-25 05:50PM	Abbott (ABT) Stock Moves -0.15%: What You Should Know (Zacks)
11:30AM	Boston Scientific (BSX) Up 3.3% Since Last Earnings Report: Can It Continue? (Zacks)
11:09AM	Abbott Laboratories (ABT) was up 16% in Q1 (Insider Monkey)
07:48AM	Was Jim Cramer Right About Abbott Laboratories (ABT)? (Insider Monkey)
06:30AM	2 Dividend Stocks to Buy With $500 and Hold Forever (Motley Fool)
May-22-25 04:33PM	From Acquisition to Advantage: Abbott's Growth in Heart Care (GuruFocus.com)
03:00PM	Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better? (Zacks)
May-21-25 09:00AM	Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know (Zacks)
May-20-25 09:41AM	Solid Results Boosted Abbott Laboratories' (ABT) Performance in Q1 (Insider Monkey)
09:30AM	Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views? (Zacks)
May-19-25 07:47AM	Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs (Zacks)
May-18-25 03:49PM	Abbott Laboratories (ABT)'s Libre Linked to Fewer Heart Hospitalizations in Diabetes (Insider Monkey)
May-17-25 06:40AM	3 Magnificent Stocks That Are Passive Income Machines (Motley Fool)
May-16-25 11:30AM	Abbott (ABT) Up 1.8% Since Last Earnings Report: Can It Continue? (Zacks)
10:25AM	Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now? (Zacks)
May-15-25 09:05AM	Abbott's Libre Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes (PR Newswire)
May-12-25 08:31AM	Abbott Laboratories (ABT) Benefitted From Better Execution (Insider Monkey)
May-10-25 08:30AM	Trump is hailing $2 trillion in new company investments. Most of it comes from Big Tech. (Yahoo Finance)
May-09-25 10:01AM	The Zacks Analyst Blog Highlights NVIDIA, Abbott Laboratories, Linde and Tredegar (Zacks)
06:31AM	Why Abbott Laboratories (ABT) is Among the Best Medical Device Stocks to Buy Now (Insider Monkey)
06:20AM	Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? (Zacks)
May-08-25 04:17PM	Top Stock Reports for NVIDIA, Abbott Laboratories & Linde (Zacks)
03:00PM	Is Medtronic Stock a Buy Pre-Q4 Earnings? Key Metrics to Watch (Zacks)
08:00AM	Cadrenal Therapeutics Reports First-Quarter 2025 Financial Results and Provides Corporate Update (Business Wire)
May-07-25 03:00PM	Abbott Outpaces Peers Defying Tariff Woes: Is ABT Stock a Smart Buy? (Zacks)
11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
09:45AM	Abbott Laboratories (ABT) Continued Sixth Straight Quarter of Double-Digit Gains (Insider Monkey)
09:00AM	Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
09:00AM	Abbott and Real Madrid Kick Off Search to Empower Young Soccer Talent (PR Newswire)
08:14AM	Jim Cramer Predicts Big Earnings for Abbott Laboratories (ABT): Libre Leads the Way! (Insider Monkey)
04:55AM	Fidelity Select Health Care Portfolio Q1 2025 Commentary (Seeking Alpha)
May-06-25 11:22AM	Tariff-driven disruptions in regulatory compliance (Medical Device Network)
09:10AM	The Zacks Analyst Blog Highlights GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific (Zacks)
06:20AM	Is American Century U.S. Quality Value ETF (VALQ) a Strong ETF Right Now? (Zacks)
12:36AM	1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar (StockStory)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Blount Sally E.	Director	Apr 30 '25	Sale	129.66	2,600	337,116	34,058	May 02 05:04 PM
SALLY E BLOUNT	Director	Apr 30 '25	Proposed Sale	129.66	2,600	337,116		Apr 30 04:23 PM
Earnhardt Lisa D	EVP AND GROUP PRESIDENT	Mar 06 '25	Option Exercise	80.98	91,167	7,382,704	163,095	Mar 07 06:55 PM
Earnhardt Lisa D	EVP AND GROUP PRESIDENT	Mar 07 '25	Option Exercise	80.98	200	16,196	72,128	Mar 07 06:55 PM
Earnhardt Lisa D	EVP AND GROUP PRESIDENT	Mar 06 '25	Sale	133.82	91,167	12,199,968	71,928	Mar 07 06:55 PM
Earnhardt Lisa D	EVP AND GROUP PRESIDENT	Mar 07 '25	Sale	136.65	200	27,329	71,928	Mar 07 06:55 PM
Lisa D. Earnhardt	Officer	Mar 07 '25	Proposed Sale	136.65	200	27,329		Mar 07 06:28 PM
Lisa D. Earnhardt	Officer	Mar 06 '25	Proposed Sale	133.82	91,167	12,199,967		Mar 06 05:47 PM
Wainer Andrea F	RETIRED EVP	Mar 03 '25	Sale	138.17	949	131,123	74,381	Mar 04 08:05 PM
Shroff Eric	Senior Vice President	Mar 03 '25	Sale	138.17	562	77,652	31,970	Mar 04 08:00 PM
Morrone Louis H.	EXECUTIVE VICE PRESIDENT	Mar 03 '25	Sale	138.17	1,111	153,507	66,878	Mar 04 07:49 PM
Moreland Mary K	EXECUTIVE VICE PRESIDENT	Mar 03 '25	Sale	138.17	791	109,292	95,583	Mar 04 07:44 PM
MCCOY JOHN A. JR.	VICE PRESIDENT AND CONTROLLER	Mar 03 '25	Sale	138.17	562	77,652	21,061	Mar 04 07:39 PM
Eric Shroff	Officer	Mar 03 '25	Proposed Sale	138.17	562	77,651		Mar 03 08:40 PM
Andrea F. Wainer	Retired Officer	Mar 03 '25	Proposed Sale	138.17	949	131,123		Mar 03 08:18 PM
Louis H. Morrone	Officer	Mar 03 '25	Proposed Sale	138.17	1,111	153,506		Mar 03 08:08 PM
Mary K. Moreland	Officer	Mar 03 '25	Proposed Sale	138.17	791	109,292		Mar 03 07:58 PM
John A. McCoy, Jr.	Officer	Mar 03 '25	Proposed Sale	138.17	562	77,651		Mar 03 07:52 PM
Ford Robert B	CHAIRMAN AND CEO	Feb 05 '25	Option Exercise	38.40	285,388	10,958,899	505,447	Feb 07 05:51 PM
Ford Robert B	CHAIRMAN AND CEO	Feb 05 '25	Sale	131.17	285,388	37,435,200	220,059	Feb 07 05:51 PM
Robert B. Ford	Officer	Feb 05 '25	Proposed Sale	131.17	285,388	37,435,238		Feb 05 06:52 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 29 '25	Option Exercise	38.40	131,360	5,044,224	316,166	Jan 31 07:16 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Option Exercise	38.40	58,428	2,243,635	243,234	Jan 31 07:16 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 29 '25	Sale	128.35	131,360	16,859,675	184,806	Jan 31 07:16 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Sale	128.07	58,428	7,482,629	184,806	Jan 31 07:16 PM
Salvadori Daniel Gesua Sive	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Option Exercise	38.40	23,771	912,806	149,468	Jan 31 07:08 PM
Salvadori Daniel Gesua Sive	EXECUTIVE VICE PRESIDENT	Jan 30 '25	Sale	128.50	23,771	3,054,574	125,697	Jan 31 07:08 PM
Morrone Louis H.	EXECUTIVE VICE PRESIDENT	Jan 28 '25	Sale	127.39	2,644	336,819	0	Jan 30 07:33 PM
Hubert L. Allen	Officer	Jan 30 '25	Proposed Sale	128.07	58,428	7,482,628		Jan 30 05:33 PM
Daniel Gesua Sive Salvadori	Officer	Jan 30 '25	Proposed Sale	128.50	23,771	3,054,573		Jan 30 05:26 PM
Hubert L. Allen	Officer	Jan 29 '25	Proposed Sale	128.35	131,360	16,859,675		Jan 29 05:30 PM
Funck, Jr. Robert E.	Officer	Nov 04 '24	Proposed Sale	120.00	15,000	1,800,000		Nov 04 04:02 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Oct 21 '24	Option Exercise	47.00	157,421	7,398,787	342,227	Oct 23 05:10 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Oct 21 '24	Sale	117.04	157,421	18,424,298	184,806	Oct 23 05:10 PM
ALLEN HUBERT L	Officer	Oct 21 '24	Proposed Sale	118.89	157,421	18,715,783		Oct 21 04:08 PM
Ford Robert B	CHAIRMAN AND CEO	Sep 12 '24	Option Exercise	47.19	141,679	6,685,975	361,738	Sep 13 05:24 PM
Ford Robert B	CHAIRMAN AND CEO	Sep 12 '24	Sale	116.41	141,679	16,493,218	220,059	Sep 13 05:24 PM
Robert B. Ford	Officer	Sep 12 '24	Proposed Sale	116.41	141,679	16,492,852		Sep 12 06:20 PM
MCCOY JOHN A. JR.	VICE PRESIDENT	Sep 04 '24	Sale	114.83	27	3,100	18,681	Sep 04 07:52 PM
Funck, Jr. Robert E.	Officer	Sep 04 '24	Proposed Sale	115.00	30,000	3,450,000		Sep 04 04:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABT

Abbott Laboratories

Upgrade your FINVIZ experience